Skip to main content
Caplight Logo









Exergyn

Exergyn

Private
DublinEnergy & Sustainabilityhttps://www.exergyn.com/

Last Round

Grant

Oct 2, 2025

Est. Valuation

$211.62M

Total Funding Raised

$43.15M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Exergyn is a cleantech company that develops solid-state heating and cooling technology using shape memory alloys to reduce greenhouse gas emissions.

Sector

Energy & Sustainability

Verticals

Energy Management, Advanced Materials, Smart Manufacturing

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

waste heat recoveryheat-to-powershape-memory alloySMAindustrial energy efficiencyheat engineclean techcleantechlow-grade heatheat pumpindustrial decarbonizationenergy recoverytechnology licensingindustrial hardware

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Exergyn Comparables

Compare Exergyn with similar companies based on industry and business-model similarity.

Exergyn comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Smarter Alloys
81%
Zuccato Energia
81%
Orcan Energy AG
81%

Exergyn Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 2, 2025
VC RoundDec 4, 2024
Series AJan 21, 2022
GrantDec 7, 2019
GrantMay 5, 2015
Seed
Apr 9, 2014

Key People

Founding team and executive leadership

Kevin O'Toole

Chief Executive Officer, Chief Technology Officer

Executive Team

Mark Connolly

Chief Operating Officer

Executive Team

Exergyn Investors

Notable investors and investment history

Exergyn investors
InvestorRounds
European Innovation Council FundGrant
McWin Capital PartnersSeries A
Carrier VenturesVC Round
MercuriaSeries A
NDRCSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 121% MoM, from 347 to 767.

  • May 5, 2015

    Secured $2.81M from the European Innovation Council Fund.

Exergyn Filings

Explore SEC and related filing metadata, where available.

Exergyn filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Exergyn's valuation, stock price, and market status.

Is Exergyn a public or private company?

Exergyn is a private company.

What is the current stock price of Exergyn?

Exergyn is a private company, so its shares have no public market price. Caplight tracks Exergyn's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Exergyn worth (valuation)?

Exergyn's valuation is estimated at $211.6M based on funding round data.

Can I buy Exergyn stock?

Exergyn shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Exergyn's last funding round?

Exergyn's most recent funding round was Grant on October 2, 2025.

Who are the main investors in Exergyn?

Key investors in Exergyn include Carrier Ventures, Mercuria, NDRC.

Will Exergyn IPO soon?

No public IPO plans have been announced for Exergyn.

How can I track Exergyn secondary market activity?

Caplight tracks bids, offers, and trades in Exergyn's shares on secondary markets.

Firmographic Details

HeadquartersDublin
Employee Range36
Year Founded2012
Last FundingOct 2, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?